Methods for Identifying Circadian Rhythm
Total Page:16
File Type:pdf, Size:1020Kb
(19) *EP003302716B1* (11) EP 3 302 716 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61Q 17/04 (2006.01) G01N 33/50 (2006.01) (2006.01) (2006.01) 14.10.2020 Bulletin 2020/42 A61Q 19/08 A61Q 19/00 C12Q 1/68 (2018.01) (21) Application number: 16729482.6 (86) International application number: (22) Date of filing: 08.06.2016 PCT/US2016/036401 (87) International publication number: WO 2016/200905 (15.12.2016 Gazette 2016/50) (54) METHODS FOR IDENTIFYING CIRCADIAN RHYTHM-DEPENDENT COSMETIC AGENTS FOR SKIN CARE COMPOSITIONS VERFAHREN ZUR IDENTIFIZIERUNG VON BIORHYTHMUSABHÄNGIGEN KOSMETISCHEN MITTELN FÜR HAUTPFLEGEZUSAMMENSETZUNGEN PROCÉDÉS D’IDENTIFICATION D’AGENTS COSMÉTIQUES DÉPENDANT DU RYTHME CIRCADIEN POUR DES COMPOSITIONS DE SOIN DE LA PEAU (84) Designated Contracting States: • OSBORNE, Rosemarie AL AT BE BG CH CY CZ DE DK EE ES FI FR GB Cincinnati, Ohio 45202 (US) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR (74) Representative: P&G Patent Belgium UK N.V. Procter & Gamble Services Company S.A. (30) Priority: 08.06.2015 US 201562172498 P Temselaan 100 1853 Strombeek-Bever (BE) (43) Date of publication of application: 11.04.2018 Bulletin 2018/15 (56) References cited: WO-A1-2010/079285 JP-A- 2010 098 965 (73) Proprietor: The Procter & Gamble Company US-A1- 2009 220 481 US-A1- 2010 028 317 Cincinnati, OH 45202 (US) US-A1- 2015 071 895 (72) Inventors: • GEYFMAN MIKHAIL ET AL: "Clock genes, hair • MULLINS, Lisa, Ann growth and aging", AGING, NEW YORK, NY, US, Cincinnati, Ohio 45202 (US) vol. 2, no. 3, 1 March 2010 (2010-03-01), pages • TAMURA, Makio 122-128, XP002630052, ISSN: 0160-2721 Cincinnati, Ohio 45202 (US) [retrieved on 2010-03-18] Note: Within nine months of the publication of the mention of the grant of the European patent in the European Patent Bulletin, any person may give notice to the European Patent Office of opposition to that patent, in accordance with the Implementing Regulations. Notice of opposition shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention). EP 3 302 716 B1 Printed by Jouve, 75001 PARIS (FR) 1 EP 3 302 716 B1 2 Description ing factors as either intrinsic or extrinsic, although these are interdependent, reflected for example by the fact that [0001] Skin is a complex, multi-layered and dynamic extrinsic factors may accelerate intrinsic aging. One ex- system that provides a protective covering defining the ample of the complex interplay of factors involves free interactive boundary between an organism and the en- 5 radicals, which are both generated internally through nor- vironment. It is the largest organ of the body and is vitally mal metabolic processes and produced as a conse- important to both our health and our self-image. The skin quence of external factors, including UVR exposure. As comprises three principal layers, the epidermis, the der- a result of the age-associated decline in protective inter- mis, and a layer of subcutaneous fat. The majority of cells nal antioxidant mechanisms, free radicals can reach in the epidermis are keratinocytes that produce a family 10 higher and sustained levels in cells and alter both proteins of proteins called keratins. The epidermis itself may be and DNA in skin. Levels of altered protein and DNA may divided into multiple layers with the outermost layer re- accumulate causing damage, sometimes referred to as ferred to as the stratum corneum, and the innermost layer oxidative stress. In addition, ongoing accumulation of referred to as the basal layer. All epidermal cells originate damage secondary to internally-generated free radicals from the basal layer and undergo a process known as 15 combined with those generated from UVR and other ex- differentiation as they gradually displace outward to the ternal assaults (surfactants, allergens, and other irritants) stratum corneum, where they fuse into squamous sheets can promote a chronic inflammatory state, which accel- and are eventually shed. In healthy, normal skin, the rate erates the aging process. For example, proteolytic en- of production is about the same as the rate of shedding zymes may be produced, resulting in collagen degrada- (desquamation). Fully mature keratinocytes function to 20 tion. In some instances, activated inflammatory cells re- protect the skin from UV light damage, and help effectu- sulting from elevations in circulating pro-inflammatory ate immune response to environmental stimuli. mediators (e.g., prostaglandins, cytokines, histamines) [0002] The dermis, which lies just beneath the epider- can produce reactive oxygen species that cause oxida- mis, is composed largely of the protein collagen, which tive damage to nucleic acids, cellular proteins, and lipids. accounts for up to 75% of the weight of the dermis and 25 Accumulated damage caused by reactive oxygen spe- is responsible for the resilience and elasticity of skin. Col- cies may stimulate a host of cytokine cascades that re- lagen bundles are held together by elastin fibers running sults in photo-aging and photo-carcinogenesis, all of through the dermis. Fibroblasts, which are the primary which can be tied to the appearance of aging skin. cells found in the dermis, function to synthesize collagen [0006] The changes caused by oxidative stress may and the dermis ground substance, which is an extracel- 30 compromise skin’s elasticity, firmness and structure, lular matrix comprising glycoproteins and gly- contributing to areas of collapse and irregularity and ul- cosaminoglycans that enmeshes fibrillar and cellular timately manifesting as fine lines, wrinkles, and texture components of the dermis. Networks of tiny blood vessels problems. There are many commercially available skin run through "rete pegs" in the dermis, bringing nutrients, care products available to consumers that are directed vitamins and oxygen to the epidermis via diffusion. 35 to improving the health and/or physical appearance of [0003] Beneath the dermis lies the hypodermis, which skin. Many such products are directed to delaying, min- comprises subcutaneous fat that cushions the dermis imizing, or even eliminating changes typically associated from underlying tissues such as muscle and bones. The with improving the appearance of aging skin. Such prod- fat is contained in adipose cells embedded in a connec- ucts typically advertise the use of one or more of cosmetic tive tissue matrix. This layer may also house the hair 40 skin-care agents known for use in improving the health follicles when they are in the growing phase. and/or appearance of skin. Accordingly, there remains a [0004] Thus, skin is a multilayered complex organ com- need to identify skin-care actives that can improve the prising a wide variety of cellular types and structures. appearance of aging skin. Skin aging is likewise a complex multi-factorial process [0007] Successful identification of new anti-aging cos- that results from unrepaired cellular and tissue damage 45 metic agents has proven to be difficult due to the multi- leading to impaired functional capacity. The aging proc- cellular, multi-factorial processes associated with skin ess in skin is the result of both intrinsic and extrinsic fac- aging. In addition, many desirable cosmetic agents may tors occurring over decades. Skin is subject to many of comprise a mixture of compounds with effects and inter- the same intrinsic aging processes as other organs, but actions that may not be fully understood. An additional is also exposed to solar radiation, pollution, cigarette 50 challenge for cosmetic formulators is that cosmetics must smoke, and other extrinsic factors that can contribute to be safe for over-the-counter consumer use. Convention- premature skin aging or photo-aging. There have been al in vitro studies of biological responses to potential cos- major advances in the understanding of the aging proc- metic agents involve screening hundreds or even thou- ess with the identification of cellular pathways and genes sands of potential agents in various cell types before an associated with longevity and aging. However, as with 55 agent that gives a desired result can be identified and aging in general, an integrated understanding of skin ag- moved into a next stage of testing. This problem may be ing has not been developed. further compounded when employing screening tech- [0005] Skin researchers have categorized age-induc- niques such as connectivity mapping or other known 2 3 EP 3 302 716 B1 4 gene response analysis techniques. Such studies can treatments. There is also a need to identify additional be hindered by the complex or weakly detectable gene cosmetic agents that provide similar or improved benefits responses typically induced and/or caused by cosmetic as compared to existing products but which are easier agents. Such weak responses arise, in part, due to the to formulate, produce, and/or market. great number of genes and gene products involved, and 5 cosmetic agents may affect multiple genes in multiple SUMMARY ways. Moreover, the degree of bioactivity of cosmetic agents may differ for each gene and be difficult to quan- [0011] Accordingly, the present invention provides tify. novel methods useful for the screening and generation [0008] Until now, skin studies typically have not taken 10 of potential cosmetic agents that work in synchronization into account the circadian rhythm of the skin and how the with the circadian rhythm of the skin for the treatment of circadian rhythm of the skin affects the efficacy of the aged skin. Through gene expression profiling and bioin- cosmetic agents. Patent application JP2010098965A formatics analysis, the present inventors have deter- discloses a screening assay for cosmetic material that mined that it is possible to derive novel and unique gene takes into account the circadian rythm of the skin.